CME & Nasdaq Extend Nasdaq-100 Futures License Through 2039

CME Group and Nasdaq have solidified their long-standing partnership with a ten-year extension of the exclusive license for Nasdaq-100 futures and options. The agreement, now valid through 2039, reinforces CME Group's position as the premier derivatives marketplace, offering unparalleled access to one of the world's most traded financial products.

The Nasdaq-100 Index, a benchmark for innovation-driven companies, continues to attract global investors seeking exposure to non-financial giants. Terry Duffy, CME Group's Chairman and CEO, emphasized the deal's role in providing capital efficiency and risk management tools for market participants navigating the equity index complex.

This extension builds on three decades of collaboration that has shaped a derivatives ecosystem supporting market integrity and investor confidence. The partnership underscores both institutions' commitment to maintaining robust financial infrastructure amid evolving economic landscapes.